Table Of Content

AUTHOR INDEX Ahdoot, M., 172 Herbertson, M.J., 125 Peterson, J.C., 1 Alfandari, S., 12 Hernan, L.J., 84 Piilonen, A., 63 Aljada, A.. 20 Hernandez, G., 73 Pinsky, M.R., 186 Andreoulakis, N., 141 Hernandez, J., 141 Augerten, A., 120 Hira, M., 114 Raszynski, A., 141 Huang, Y, 172 Reinhart, K., 29, 78 Bander, J., 69 Hultquist, K., 141 Robert, R., 114 Barrera, R., 172 Hynninen, M., 63 Rotta, A.T., 20, 84 Barzilay, Z., 120 Roussos, C., 39 Beaucaire, G., 12 Jager, L., 29 Russell, J.A., 125 Bellomo, R., 186 Jacka, M.J., 198 Ben-Abraham, R.., Jakob, H., 133 Sackner, M.A., 177 Bloch, K.E., 177 Jousela, I., 63 Saidel, G.M., 151 Bredle, D.L., 78 Jugoon, S., 177 Sakka, S.G., 78 Bugedo, G., 73 Schmidt, H., 99 Kalhan, S.C., 151 Schmidt, W., 99 Cabrera, M.E., 151 Kellum, J.A., 186 Schnabel, P.A., 133 Camacho, M.T., 191 Kim, Y.M., 186 Schweppenhiuser, W., 99 Carlet, J., 7 Kolkman, J.J., 34 Secchi, A., 99 Castillo, L., 73 Kramer, G.C., 93 Shelly, M., 69 Cheval, C., 7, 107 Kuusela, P., 63 Sinuff, T., 1, 199 Choisy, P., 12 Slotman, G., 69 Cook, D.J., 1, 199 Lagonidis, D., 164 Steinhorn, D.M., 20, 84 Lancaster, J.R. Jr., 186 Sussmane, J., 141 Dandona, P., 20 Lang, J.D. Jr., 93 DeFigueiredo, L. P., 93 LeCorre, F., 107 Takkunen, O., 63 De Jonghe, B., 7 Leroy, O., 12 Tanigawa, K., 186 Doré, P., 114 Leung, D., 172 Tenaillon, A., 69 Dupont, H., 107 Lopez, F., 73 Timsit, J.-F., 7, 107 Torbati, D., 191 Evans, D.J., 93 Magder, S., 164 Totapally, B.R., 141, 191 Maiz, A., 73 Fauchére, J.-L., 114 Markkanen, H., 63 Vaara, M., 63 Ferrand, E., 114 Martin, E., 99, 133 Valtonen, M., 63 Fierobe, L., 107 Mathru, M., 93 Van Leuwen, P.A., 69 Friedman, G., 69 Meade, M.O., 198 Vardi, A., 120 Fuhrman, B.P., 20, 84 Meier-Hellmann, A., 78 Vargas, C., 73 Fuller, H.D., 1 Melendez, J., 172 Vassilakopoulos, T., 39 Meuwissen, S.G.M., 3 Velasco, N.. 73 Garrouste, M., 7 Misset, B.. 7 Vincent, J.-L., 69 Gebhard, M.-M., 99, 133 Moine, P., 107 Vogelsang, H., 29 Georges, H., 12 Montuclard, L., 7 Groeger, J.S., 172 Moreh, O., 120 Wainstein, C., 73 Groeneveld, A.B.J., 34 Motsch, J., 133 Walley, K.R., 1 + 5 Grollier, G., 114 Weimann, J., 13-3: ~4 Guery, B., 12 Nasraway, S., 69 Wolfsdorf, J.. 141, 191 Guilley, J., 12 Gunnarsson, B., 84 Oberhoffer, M., 29 Zakynthinos, S., 39 Guzman, S., 73 Ondulick, B., 186 Zar, H., 186 Zink, W., 133 Harel, R., 120 Papo, M.C.., 20 Hays, S., 93 Paret, G., 120 Journal of Critical Care, Vol 14, No 4 (December), 1999: p 201 SUBJECT INDEX Adult respiratory distress syndrome (ARDS) Hospital-acquired ventilator-associated pneumonia, CAP mor- inhaled nitric oxide salvage therapy for, 107-113 tality and, 12-19 ketaconazole prophylaxis for, 1-6, 198(letter), 199(reply) Hypercapnia, arterial oxygen-carrying capacity and, 191-197 prognostic respiratory variables, adapting for children, Hypoxemia, weaning failure and, 47 120-124 Albumin, vs. saline, as volume challenge in post-cardiac surgery IL-lra. See Interleukin | receptor antagonist patients, 164-171 Inductance cardiography, for left ventricular filling monitor- Antimicrobial therapy ing, 177-185 anti-anaerobic, for nosocomial pneumonia, 114-119 Interleukin | receptor antagonist (IL-|ra) with ketaconazole, for ARDS prophylaxis, 1-6, 198(letter), cardiac function in sepsis and, 69-72 199(reply) in pancreatitis vs. sepsis, 63-68 ARDS. See Adult respiratory distress syndrome Intrathoracic blood volume, vs. cardiac filling pressure in sepsis/ Arterial oxygen-carrying capacity, hypercapnia effect on, 191- septic shock, 78-83 197 Ischemia lactate accumulation during, model analysis of, 151-163 Bladder mucosa, Pco,, Po, and pHi for tissue perfusion monitor- tissue perfusion monitoring, bladder mucosal Pco,, Po, and ing, 93-98 pHi for, 93-98 Blood flow Katacalcin immunoreactivity, leukocyte procalcitonin content intestinal villous, during endotoxemia, 99-105 and, 29-33 regional, nitric oxide metabolism in sepsis and, 186-190 Ketaconazole, for ARDS _ prophylaxis, 1-6, 198(letter), 199(reply) Calcitonin immunoreactivity, leukocyte procalcitonin content and, 29-33 Lactate Cardiac filling pressure, vs. intrathoracic blood volume in sepsis/ accumulation during muscle ischemia, 151—163 septic shock, 78-83 early hepatic dysfunction in acute circulatory failure and, 7-11 Cardiac function, in sepsis, IL-Ira and, 69-72 Left ventricular end-diastolic pressure, weaning failure and, 45 Cardiopulmonary bypass surgery, postoperative volume chal- Left ventricular filling, inductance cardiography of, 177-185 lenge, 164-171 Leukocytes, procalcitonin content in, 29-33 Cardiovascular dysfunction, weaning failure and, 45-46 Liquid ventilation Children, ARDS prognostic respiratory variables for, 120-124 attenuation of pulmonary oxidative damage, 20-28 Circulatory failure, early liver dysfunction and blood lactate partial, acute lung injury histopathology and, 84-92 in, 7-11 Liver dysfunction, in acute circulatory failure, blood lactate Community-acquired pneumonia mortality, HA-VAP impact and, 7-11 on, 12-19 Lung injury, pulmonary histopathology, partial liquid ventilation and, 84-92 Dobutamine infusion, myocardial oxygen consumption during, 125-132 Mechanical ventilation flow triggering with pressure support ventilation during, E-selectin, in pancreatitis vs. sepsis, 63-68 172-176 Endotoxemia hypercapnia effect on arterial oxygen-carrying capacity, 191— dobutamine infusion for, myocardial oxygen consumption 197 during, 125-132 inappropriate relationship of needs and neurorespiratory ca- intestinal villous blood flow during, 99-105 pacity, 39-45 Enteral nutrition, short fasting period, gut mucosal atrophy reduction of duration, 47-52 after, 73-77 weaning from. See Weaning Epinephrine, intestinal villous blood flow during endotoxemia Microembolism, sustained pulmonary hypertension for, 133- and, 99-105 140 Muscle ischemia. See Ischemia Fasting, gut mucosal atrophy after, 73-77 Myocardial oxygen consumption, during dobutamine infusion Flow triggering, with pressure support ventilation during sponta- in endotoxemia, 125-132 neous breathing, 172-176 Nasal intermittent positive-pressure ventilation (NIPPV), 57-58 Gastric feeding, effect on intragastric PCO, tonometry, 34-38 Nitric dioxide, concentration during high-frequency oscillatory Gastric intramural pH, weaning failure and, 47 ventilation, 141-147 Gut mucosal atrophy, after short enteral fasting period, 73-77 Nitric oxide as ARDS salvage therapy, 107-113 Heart function, in sepsis, IL-lra and, 69-72 concentration during high-frequency oscillatory ventilation, High-frequency oscillatory ventilation, nitric oxide and nitrogen 141-147 dioxide concentrations during, 141-147 metabolism, in canine sepsis, 186-190 202 Journal of Critical Care, Vol 14, No 4 (December), 1999: pp 202-203 SUBJECT INDEX 203 Nitric oxide (Continued) Reperfusion, bladder mucosal tissue perfusion monitoring, selective vasodilation by inhalation, during sustained pulmo- 93-98 nary hypertension, 133-140 Norepinephrine, intestinal villous blood flow during endotoxe- Sepsis mia and, 99-105 canine, nitric oxide metabolism in, 186-190 Nosocomial pneumonia cardiac function in, IL-Ira and, 69-72 anti-anaerobic antimicrobial therapy for, 114-119 IL-1ra and E-selectin levels vs. pancreatitis, 63-68 ventilator-associated, effect on community-acquired pneumo- intrathoracic blood volume vs. cardiac filling pressures in, nia mortality, 12-19 78-83 Septic shock, intrathoracic blood volume vs. cardiac filling pres- Organ failure development, weaning failure and, 46-47 sure in, 78-83 Oxygen cost of breathing, weaning failure and, 46-47 Spontaneous breathing flow triggering with pressure support ventilation during, Pancreatitis, IL-lra and E-selectin levels vs. sepsis, 63-68 176 Pco, tonometry, intragastric, effect of gastric feeding on, 34-38 initial trial of, 51-52 Peak inspiratory pressure (PIP), ARDS prognosis in children Stealing effect theory, weaning failure and, 46-47 and, 120-124 PEEP. See Positive end-expiratory pressure Tension-time index, in weaning, 40 pHI, weaning failure and, 47 Thoracocardiography, for left ventricular filling monitoring, PIP (peak inspiratory pressure), ARDS prognosis in children 177-185 and, 120-124 Tissue perfusion monitoring, bladder mucosal, 93-98 Pneumonia Tracheal gas insufflation, for weaning, 57 community-acquired, mortality from, 12-19 hospital-acquired ventilator-associated, 12-19 Ventilation index, prognostic value in children with ARDS, nosocomial, anti-anaerobic antimicrobial therapy for, 114-119 120-124 Positive end-expiratory pressure (PEEP) Ventilator-associated pneumonia, CAP mortality and, 12-19 ARDS prognosis in children and, 120-124 Ventilatory techniques, for weaning, 53-58 intrinsic, counterbalance of, 53 Vopresp, weaning failure and, 46-47 Pressure support ventilation, with flow triggering during sponta- Volume challenge, in post-cardiac surgery patients, 164-171 neous breathing in intubated patients, 172-176 Procalcitonin, content in leukocytes, 29-33 Weaning Pulmonary hypertension, sustained, nitric oxide inhalation selec- difficult, strategies/techniques for, 52-53 tive vasodilation by, 133-140 failure, etiology/pathophysiology of, 39-47 partial support, 5S—57 Reactive oxygen species, attenuation of pulmonary oxidative reduction of duration of mechanical ventilation and, 47-52 damage, 20-28 spontaneous breathing, initial trial of, 51-52 Regional blood flow, nitric oxide metabolism in sepsis and, T-piece, 53, 55 186-190 tracheal gas insufflation for, 57